<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-0420</journal-id>
<journal-title><![CDATA[Revista Uruguaya de Cardiología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev.Urug.Cardiol.]]></abbrev-journal-title>
<issn>1688-0420</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Uruguaya de Cardiología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-04202024000101403</article-id>
<article-id pub-id-type="doi">10.29277/cardio.39.1.13</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Lo mejor del Congreso ACC 2024]]></article-title>
<article-title xml:lang="en"><![CDATA[The best of ACC Congress 2024]]></article-title>
<article-title xml:lang="pt"><![CDATA[O melhor do Congresso ACC 2024]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Márquez]]></surname>
<given-names><![CDATA[Matías]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Olivera]]></surname>
<given-names><![CDATA[Jéssica]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ferrando-Castagnetto]]></surname>
<given-names><![CDATA[Federico]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Médica Uruguaya Corporación de Asistencia Médica Cardiología ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af2">
<institution><![CDATA[,Dirección Nacional de Sanidad de las Fuerzas Armadas Cardiología ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af3">
<institution><![CDATA[,UDELAR. Facultad de Medicina Unidad Académica de Cardiología, Centro Cardiovascular Universitario. Hospital de Clínicas Dr. Manuel Quintela]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<volume>39</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-04202024000101403&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-04202024000101403&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-04202024000101403&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen Entre el 6 y el 8 de abril de 2024 se llevó a cabo el Congreso Anual del Colegio Americano de Cardiología (American College of Cardiology, ACC). El esperado evento tuvo como sede al Georgia World Congress Center, en Atlanta (Estados Unidos). Allí se dispusieron cientos de sesiones educativas y se presentaron los principales resultados de las investigaciones clínicas actuales en 11 áreas de interés como &#8220;vías de aprendizaje&#8221;. Las sesiones científicas fueron extensas y ocuparon todo el horario durante los tres días del Congreso, con presentaciones orales, e-pósters y pósters orales. Entre las muchas investigaciones de gran calidad y valioso aporte para nuestra práctica clínica, realizamos una breve selección de algunos de ellos, incluimos cuatro grandes ensayos y una experiencia observacional destacada de menor escala que aplicó inteligencia artificial. Se resumen los hallazgos más importantes de: &#8226; Betabloqueantes después del infarto de miocardio con fracción de eyección preservada: REDUCE AMI TRIAL. &#8226; Tratamiento transcatéter o quirúrgico de la estenosis valvular aórtica: DEDICATE. &#8226; Empagliflozina tras el infarto agudo de miocardio: EMPACT MI. &#8226; Ticagrelor solo vs. ticagrelor más aspirina desde el primer al décimo segundo mes después del intervencionismo coronario percutáneo en pacientes con síndromes coronarios agudos: ULTIMATE-DAPT. &#8226; Análisis de conglomerados (clusters) basado en el aprendizaje automático identifica los fenotipos de los pacientes con riesgo de recurrencia de arritmia auricular tras la ablación con catéter de la fibrilación auricular paroxística.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract The annual meeting of the American College of Cardiology (ACC) was held from April 6.th to 8.th, 2024. The long-awaited event was held at the Georgia World Congress Center in Atlanta. Hundreds of educational sessions were held there and the main results of current clinical research in 11 areas of interest were presented as &#8220;learning pathways&#8221;. The scientific sessions were extensive and took up all the time during the three days of the Congress, with oral presentations, e-posters and oral posters. Among the research of high quality and valuable contribution to our clinical practice, we selected some of them, including five large trials and a smaller-scale observational experience that applied artificial intelligence. We summarize the most important findings of: &#8226; Beta-blockers after myocardial infarction and preserved ejection fraction: REDUCE AMI TRIAL. &#8226; Transcatheter or surgical treatment of aortic-valve stenosis: DEDICATE. &#8226; Empagliflozin after acute myocardial infarction: EMPACT MI. &#8226; Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes: ULTIMATE-DAPT. &#8226; Cluster analysis based on machine learning identifies patient phenotypes at risk of atrial arrhythmia recurrence after catheter ablation in paroxystic atrial fibrillation.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo A reunião anual do American College of Cardiology (ACC) foi realizada de 6 a 8 de abril de 2024. O evento altamente aguardado ocorreu no Georgia World Congress Center, em Atlanta. Ali foram realizadas centenas de sessões educativas e os principais resultados da pesquisa clínica atual em 11 áreas de interesse foram apresentados como &#8220;caminhos de aprendizagem&#8221;. As sessões científicas foram extensas e ocuparam todo o tempo durante os três dias do Congresso, com apresentações orais, e-posters e posters orais. Entre as pesquisas de alta qualidade e valiosa contribuição para a nossa prática clínica, selecionamos algumas delas, incluindo cinco grandes ensaios e um experimento observacional de menor escala que aplicou inteligência artificial, resumindo suas descobertas mais importantes. &#8226; Betabloqueadores após infarto do miocárdio com fração de ejeção preservada: REDUCE AMI TRIAL. &#8226; Tratamento transcateter ou cirúrgico da estenose da valva aórtica: DEDICATE. &#8226; Empagliflozina após infarto agudo do miocárdio: EMPACT MI. &#8226; Ticagrelor sozinho versus ticagrelor mais aspirina do primer ao décimo segundo mês após intervenção coronária percutânea em pacientes com síndromes coronarianas agudas: ULTIMATE-DAPT. &#8226; Análise de cluster baseada em aprendizado de máquina identifica fenótipos de pacientes com risco de recorrência de arritmia atrial após ablação por cateter de fibrilação atrial paroxística.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[REDUCE AMI TRIAL]]></kwd>
<kwd lng="es"><![CDATA[DEDICATE]]></kwd>
<kwd lng="es"><![CDATA[EMPACT MI TRIAL]]></kwd>
<kwd lng="es"><![CDATA[ULTIMATE-DAPT]]></kwd>
<kwd lng="es"><![CDATA[RECURRENCIA ARRITMIA AURICULAR.]]></kwd>
<kwd lng="en"><![CDATA[REDUCE AMI TRIAL]]></kwd>
<kwd lng="en"><![CDATA[DEDICATE]]></kwd>
<kwd lng="en"><![CDATA[EMPACT MI TRIAL]]></kwd>
<kwd lng="en"><![CDATA[ULTIMATE-DAPT]]></kwd>
<kwd lng="en"><![CDATA[ATRIAL ARRHYTHMIA RECURRENCE]]></kwd>
<kwd lng="pt"><![CDATA[REDUCE AMI TRIAL]]></kwd>
<kwd lng="pt"><![CDATA[DEDICATE]]></kwd>
<kwd lng="pt"><![CDATA[EMPACT MI TRIAL]]></kwd>
<kwd lng="pt"><![CDATA[ULTIMATE-DAPT]]></kwd>
<kwd lng="pt"><![CDATA[RECORRÊNCIA DE ARRITMIA ATRIAL]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bangalore]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Makani]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Radford]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Thakur]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Toklu]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Katz]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical outcomes with ß-blockers for myocardial infarction a meta-analysis of randomized trials]]></article-title>
<source><![CDATA[Am J Med]]></source>
<year>2014</year>
<volume>127</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>939-53</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Byrne]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Rossello]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Coughlan]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Barbato]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Berry]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Chieffo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2023 ESC Guidelines for the management of acute coronary syndromes]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2023</year>
<volume>44</volume>
<numero>38</numero>
<issue>38</issue>
<page-range>3720-826</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yndigegn]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Lindahl]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Mars]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Alfredsson]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Benatar]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Brandin]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Beta-blockers after myocardial infarction and preserved ejection fraction]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2024</year>
<volume>390</volume>
<numero>15</numero>
<issue>15</issue>
<page-range>1372-81</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Steg]]></surname>
<given-names><![CDATA[PG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Routine Beta-Blockers in Secondary Prevention - On Injured Reserve]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2024</year>
<volume>390</volume>
<numero>15</numero>
<issue>15</issue>
<page-range>390</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Otto]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Nishimura]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Bonow]]></surname>
<given-names><![CDATA[RO]]></given-names>
</name>
<name>
<surname><![CDATA[Carabello]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Erwin JP]]></surname>
<given-names><![CDATA[III]]></given-names>
</name>
<name>
<surname><![CDATA[Gentile]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2020 ACC/AHA guideline for the management of patients with valvular heart disease a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2021</year>
<volume>143</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>e35-71</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vahanian]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Beyersdorf]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Praz]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Milojevic]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Baldus]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bauersachs]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guía ESC/EACTS 2021 sobre el diagnóstico y tratamiento de las valvulopatías.]]></article-title>
<source><![CDATA[Rev Esp Cardio]]></source>
<year>2022</year>
<volume>75</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>524.e1-524.e69</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mack]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Leon]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Thourani]]></surname>
<given-names><![CDATA[VH]]></given-names>
</name>
<name>
<surname><![CDATA[Pibarot]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Hahn]]></surname>
<given-names><![CDATA[RT]]></given-names>
</name>
<name>
<surname><![CDATA[Genereux]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transcatheter aortic-valve replacement in low-risk patients at five years]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2023</year>
<volume>389</volume>
<numero>21</numero>
<issue>21</issue>
<page-range>1949-60</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Popma]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Deeb]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Yakubov]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Mumtaz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gada]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients]]></article-title>
<collab>O'Hair D</collab>
<source><![CDATA[N Engl J Med]]></source>
<year>2019</year>
<volume>380</volume>
<numero>18</numero>
<issue>18</issue>
<page-range>1706-15</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Blankenberg]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Seiffert]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vonthein]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Baumgartner]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Bleiziffer]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Borger]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transcatheter or surgical treatment of aortic-valve stenosis]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2024</year>
<volume>390</volume>
<numero>17</numero>
<issue>17</issue>
<page-range>1572-83</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[PB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Another early win for TAVI in low-risk patients]]></article-title>
<source><![CDATA[NJEM]]></source>
<year>2024</year>
<volume>390</volume>
<numero>17</numero>
<issue>17</issue>
<page-range>1623-5</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cunningham]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
<name>
<surname><![CDATA[Vaduganathan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Claggett]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
<name>
<surname><![CDATA[Kulac]]></surname>
<given-names><![CDATA[IJ]]></given-names>
</name>
<name>
<surname><![CDATA[Desai]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Jhund]]></surname>
<given-names><![CDATA[PS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dapagliflozin in patients recently hospitalized with heart failure and mildly reduced or preserved ejection fraction]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2022</year>
<volume>80</volume>
<numero>14</numero>
<issue>14</issue>
<page-range>1302-10</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tomasoni]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Fonarow]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
<name>
<surname><![CDATA[Adamo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Anker]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Butler]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sodium-glucose co-transporter 2 inhibitors as an early, first-line therapy in patients with heart failure and reduced ejection fraction]]></article-title>
<source><![CDATA[Eur J Heart Fail]]></source>
<year>2022</year>
<volume>24</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>431-41</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Butler]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[WS]]></given-names>
</name>
<name>
<surname><![CDATA[Udell]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Anker]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Petrie]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Harrington]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Empagliflozin after acute myocardial infarction]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2024</year>
<volume>390</volume>
<numero>16</numero>
<issue>16</issue>
<page-range>1455-66</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[AF]]></given-names>
</name>
<name>
<surname><![CDATA[Udell]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[WS]]></given-names>
</name>
<name>
<surname><![CDATA[Anker]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Petrie]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Harrington]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of Empagliflozin on heart failure outcomes after acute myocardial infarction insights from the EMPACT-MI Trial]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2024</year>
<volume>149</volume>
<numero>21</numero>
<issue>21</issue>
<page-range>1627-38</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Byrne]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Xavier Rosselló]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Coughlan]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Barbato]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Berry]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Chieffo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2023 ESC guidelines for the management of acute coronary syndromes]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2023</year>
<volume>44</volume>
<numero>38</numero>
<issue>38</issue>
<page-range>3720-826</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ge]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Kan]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gao]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Raza]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Mohydin]]></surname>
<given-names><![CDATA[BS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ticagrelor solo versus ticagrelor más aspirina desde el mes 1 hasta el mes 12 después de la intervención coronaria percutánea en pacientes con síndromes coronarios agudos (ULTIMATE-DAPT) un ensayo clínico aleatorizado, controlado con placebo, doble ciego]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2024</year>
<volume>403</volume>
<numero>10439</numero>
<issue>10439</issue>
<page-range>1866-78</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kosich]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Schumacher]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Potpara]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Lip]]></surname>
<given-names><![CDATA[GY]]></given-names>
</name>
<name>
<surname><![CDATA[Hindricks]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Kornej]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical scores used for the prediction of negative events in patients undergoing catheter ablation for atrial fibrillation Clin]]></article-title>
<source><![CDATA[Cardiol]]></source>
<year>2019</year>
<volume>42</volume>
<page-range>320-9</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Deng]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Liao]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Fang]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Zhan]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Wei]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An artificial intelligence-enabled ECG algorithm for predicting the risk of recurrence in patients with paroxysmal atrial fibrillation after catheter ablation]]></article-title>
<collab>etal</collab>
<source><![CDATA[J Clin Med]]></source>
<year>2023</year>
<volume>12</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1933</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Budzianowski]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kaczmarek-Majer]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Rzezniczak]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Slomczynski]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wichrowski]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Hiczkiewicz]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Machine learning model for predicting late recurrence of atrial fibrillation after catheter ablation]]></article-title>
<source><![CDATA[Sci Rep]]></source>
<year>2023</year>
<volume>13</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>15213</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
